Detailed View
RCUS - Arcus Biosciences, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
3,897,710,080
Adj EBIT (TTM)
-398,000,000
Enterprise Value
3,696,710,080
Last Price
30.99
Earnings Yield
-10.77%
Return on Capital
-50.51%
Capital
788,000,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 17,000,000 | -134,000,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 33,000,000 | -114,000,000 |
| 2025-09-30 | 10-Q | 2025 | 26,000,000 | -142,000,000 |
| 2025-06-30 | 10-Q | 2025 | 160,000,000 | -8,000,000 |
| 2025-03-31 | 10-Q | 2025 | 28,000,000 | -122,000,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 26,000,000 | -103,000,000 |
| 2024-09-30 | 10-Q | 2024 | 48,000,000 | -105,000,000 |
| 2024-06-30 | 10-Q | 2024 | 39,000,000 | -106,000,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.